Literature DB >> 13812929

The chemotherapy of tuberculosis. With special reference to patients whose bacilli are resistant to the standard drugs.

J CROFTON.   

Abstract

Entities:  

Keywords:  ANTITUBERCULAR AGENTS/therapy

Mesh：

Substances：

Year:  1960        PMID： 13812929     DOI： 10.1093/oxfordjournals.bmb.a069793

Source DB:  PubMed          Journal:  Br Med Bull        ISSN： 0007-1420            Impact factor:   4.291


× No keyword cloud information.
  3 in total

1.  Comparative value of sputum smear examination and culture examination in assessing the progress of tuberculous patients receiving chemotherapy.

Authors:  S Devadatta; S Radhakrishna; W Fox; D A Mitchison; S Rajagopalan; S Sivasubramanian; H Stott
Journal:  Bull World Health Organ       Date:  1966       Impact factor: 9.408

2.  Drug resistance beyond extensively drug-resistant tuberculosis: individual patient data meta-analysis.

Authors:  G B Migliori; G Sotgiu; N R Gandhi; D Falzon; K DeRiemer; R Centis; M G Hollm-Delgado; D Palmero; C Pérez-Guzmán; M H Vargas; L D'Ambrosio; A Spanevello; M Bauer; E D Chan; H S Schaaf; S Keshavjee; T H Holtz; D Menzies
Journal:  Eur Respir J       Date:  2012-10-11       Impact factor: 16.671

3.  Resistance to fluoroquinolones and second-line injectable drugs: impact on multidrug-resistant TB outcomes.

Authors:  Dennis Falzon; Neel Gandhi; Giovanni B Migliori; Giovanni Sotgiu; Helen S Cox; Timothy H Holtz; Maria-Graciela Hollm-Delgado; Salmaan Keshavjee; Kathryn DeRiemer; Rosella Centis; Lia D'Ambrosio; Christoph G Lange; Melissa Bauer; Dick Menzies
Journal:  Eur Respir J       Date:  2012-10-25       Impact factor: 16.671
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.